Factset Research Systems

FDS · NYSE

$312.27+$9.06 (+2.99%)TodayMarket closed · Oct 20, 6:30 PM ET

Prev close $303.21

FDS analyst rating

HoldConsensus of 14 analysts over the last 12 months. 14% rate it a buy.

Strong buy0
Buy2
Hold7
Underperform4
Sell1

12-month price target · 19 analysts

Average $292.07 (−6.5% downside)

Low: $214.12
Now: $312.27
High: $451.50

Upgrades and downgrades

The latest rating actions, newest first

FDS analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
BMO Capital	Oct 13, 2026	Maintains	Market Perform	$300.00 → $314.00	60%
Wells Fargo	Oct 1, 2026	Maintains	Underweight	$210.00 → $250.00	46%
Stifel	Oct 1, 2026	Maintains	Hold	$254.00 → $292.00	56%
Deutsche Bank	Sep 11, 2026	Maintains	Hold	$280.00 → $299.00	56%
Morgan Stanley	Sep 10, 2026	Maintains	Equal-Weight	$230.00 → $300.00	48%
William Blair	Sep 8, 2026	Upgrade	Market Perform → Outperform	—	80%
Barclays	Sep 8, 2026	Maintains	Underweight	$216.00 → $250.00	64%
RBC Capital	Aug 27, 2026	Maintains	Sector Perform	$240.00 → $304.00	64%
Barclays	Jul 6, 2026	Maintains	Underweight	$210.00 → $216.00	64%
Jefferies	Jul 2, 2026	Maintains	Hold	$225.00 → $253.00	44%

The case for and against

Updated Oct 17, 2026

Bull case

FactSet Research Systems is benefiting from durable demand for its financial data and analytics, with 3Q26 organic ASV up 7.1% year over year to $2,484.3m and buy-side, wealth, and banking clients driving broad-based adoption. Its outlook is strengthened by enterprise agreements that extend average contract duration by over 30%, strong pricing power, and AI monetization that contributed about 10% of net new ASV in 3Q26 while expanding usage of MCP and Workstation. Even with heavier 2H26 investment and elevated compensation costs, management expects productivity gains, margin expansion, and continued market-share gains from the Portware, BISAM, and CUSIP Global Services portfolio.

Bear case

FactSet Research Systems is facing a negative fundamental setup because its usage-based enterprise contracts could decouple ASV from recognized revenue if overages and consumption trends do not translate smoothly into bookings. Margin pressure is building from roughly 250bps of growth investments, a 7.0% rise in people-related expenses in 3Q26, a 14.1% increase in technology spend, and flat price realization against its rate card as inflation eases. Competitive intensity from S&P CapIQ, Refinitiv, Bloomberg, and MSCI, along with longer sales cycles and pricing pressure in multi-year retention deals, raises the risk of slower revenue growth, margin contraction in CY27E, and weaker earnings momentum.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.